Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 173941 - 173960 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01ED01) crizotinib | XALKORI | 250MG, 250MG CPS DUR 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01ED03) alectinib | ALECENSA | 150MG, 150MG CPS DUR 224(4X56) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01ED04) brigatinib | ALUNBRIG | 180MG, 180MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S,VallensbaekStrand |
| Czech Republic | (L01ED04) brigatinib | ALUNBRIG | 30MG, 30MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S,VallensbaekStrand |
| Czech Republic | (L01ED04) brigatinib | ALUNBRIG | 90MG, 90MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S,VallensbaekStrand |
| Czech Republic | (L01ED04) brigatinib | ALUNBRIG | 90MG+180MG, 90MG+180MG TBL FLM 7X90MG+21X180MG , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S,VallensbaekStrand |
| Czech Republic | (L01EE01) trametinib | MEKINIST | 0,5MG, 0,5MG TBL FLM 30 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EE01) trametinib | MEKINIST | 2MG, 2MG TBL FLM 30 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EE03) binimetinib | MEKTOVI | 15MG, 15MG TBL FLM 84 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | PIERREFABREMEDICAMENT,Lavaur |
| Czech Republic | (L01EE04) selumetinib | KOSELUGO | 10MG, 10MG CPS DUR 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | AstraZenecaAB,Södertälje |
| Czech Republic | (L01EE04) selumetinib | KOSELUGO | 25MG, 25MG CPS DUR 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | AstraZenecaAB,Södertälje |
| Czech Republic | (L01EF01) palbociclib | IBRANCE | 100MG, 100MG TBL FLM 21 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EF01) palbociclib | IBRANCE | 125MG, 125MG TBL FLM 21 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EF01) palbociclib | IBRANCE | 75MG, 75MG TBL FLM 21 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EF02) ribociclib | KISQALI | 200MG, 200MG TBL FLM 63 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EF03) abemaciclib | VERZENIOS | 100MG, 100MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V.,Utrecht |
| Czech Republic | (L01EF03) abemaciclib | VERZENIOS | 150MG, 150MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V.,Utrecht |
| Czech Republic | (L01EF03) abemaciclib | VERZENIOS | 50MG, 50MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V.,Utrecht |
| Czech Republic | (L01EG01) temsirolimus | TORISEL | 30MG, 30MG INF CSL LQF 1+1X2,2ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Lymphoma, Mantle-Cell | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | AFINITOR | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited,Dublin |
Pages
